Welcome to the e-CCO Library!

P103: Identifying CES-1 positive myeloid cells with mass cytometry as a potential therapeutic target for Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: HagemanMD, I.(1);Elfiky, A.(2);Becker, M.(2);Joustra, V.(1);Buskens, C.(3);Li Yim, A.(2);Hakvoort, T.(2);Verhoeff, J.(4);Garcia Vallejo, J.(4);D'Haens, G.(1);Wildenberg, M.(2);De Jonge, W.(2);
Created: Friday, 11 February 2022, 3:52 PM
P103: Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool
Year: 2021
Source: ECCO'21 Virtual
Authors: Pulley, J.(1);Galloway, D.(1);Oh, Y.(2);Devine, J.(3);Petrek, H.(2);Khavarian, A.(2);Matsui, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P103: Selective M1 macrophage polarisation in Crohn’s disease in comparison to intestinal tuberculosis: a novel observation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Das1, S. Pilli2, T. Kumar1, R. Rampal2, I. A. Khan2, A.K. Singh2, D. Kumar3, V. Ahuja*2

Created: Friday, 22 February 2019, 9:49 AM
P103: The identification of lesion-specific gene expression in intestinal epithelial cells of ulcerative colitis by comparing colonic organoids from lesion and non-lesion parts of same patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Nishimura1*, K. Tsuchiya1, T. Shirasaki1, S. Watanabe1, S. Hibiya1, R. Okamoto2, T. Nakamura3, M. Watanabe1

Created: Thursday, 21 February 2019, 9:14 AM
P104 Defective metabolism mediates NK cell dysfunction in inflammatory bowel disease (IBD)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Zaiatz Bittencourt1, E. Ryan2, F. Jones1, G. Doherty1

Created: Thursday, 30 January 2020, 10:12 AM
P104: Exploring the transcriptomic miRNA signatures of Egyptian Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khaled, M.(1)*;Hamdy, K.(2);Abou-Aisha, K.(3);Mansour, M.(4);
Created: Friday, 14 July 2023, 10:48 AM
P104: Gene expression profiles in inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients differ depending on the age at diagnosis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Verstockt1*, B. Verstockt2,3, J. Van Bouwel4,5, W. Meert4,5, A. Cortes Calabuig5, V. Brys4,5, V. Ballet2, E. Glorieus6, M. De Decker7, G. Van Assche2,3, P. Hindryckx6, M. Ferrante2,3, D. Laukens6, F. Mana7, M. De Vos6, S. Vermeire2,3, I. Cleynen1

Created: Thursday, 21 February 2019, 9:14 AM
P104: Icariin Attenuates Intestinal Inflammation through Inhibition of the Nuclear Factor-ĸB signaling
Year: 2022
Source: ECCO'22
Authors: Soh, H.(1);Park, S.(2);Lee, H.J.(1);Koh, S.J.(1);Im, J.P.(1);Kim, J.S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P104: Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: Mesonero Gismero, F.(1);Zabana, Y.(2);Fernández-Clotet, A.(3);Sola, A.(4);Caballol, B.(3);Leo, E.(4);García, M.J.(5);Bertoletti, F.(6);Alejandro, M.(7);Suris, G.(8);Casis, B.(9);Ferreiro-Iglesias, R.(10);Calafat, M.(11);Jiménez, I.(12);Miranda-Bautista, J.(13);Lamuela, L.J.(14);Fajardo, I.(15);Torrealba, L.(16);Nájera, R.(17);Sáiz, R.M.(18);González, I.(19);Vicuña, M.(20);García-Morales, N.(21);Gutiérrez, A.(22);López-García, A.(23);Benítez, J.M.(24);Rubín de Célix, C.(25);Tejido, C.(26);Brunet, E.(27);Bastón, I.(10);Rodríguez-Lago, I.(12);Baltar, R.(28);Huguet, J.M.(29);Hermida, B.(30);Caballero-Mateos, A.(31);Sánchez-Guillén, L.(32);Bouhmidi, A.(33);Pajares, R.(34);López-Sanromán, A.(1);Barreiro-de Acosta, M.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P104: Monitoring inflammatory activity in Crohn’s disease: simple ultrasonographic score vs. CEUS which one to use?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Arieira*1,2,3, S. Monteiro1,2,3, F. Dias de Castro1,2,3, J. Magalhães1,2,3, S. Leite1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P104: Rebamipide, sucralfate, and rifaximin have the suppressive effects on radiation-induced inflammation in the intestine of mouse
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Moon W., Park S.J., Kim J.H., Park M.I., Kim S.E., Jung K.W.

Created: Wednesday, 20 February 2019, 10:36 AM
P104: Risk factors associated with the negativisation of anti-HBs antibodies in inflammatory bowel disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. C. Marín*1, M. Chaparro1, M. Ramas1, R. R. Ribot1, P. M. Linares1, J. R. Villagrasa2, D. Bernardo1, J. P. Gisbert1

Created: Friday, 22 February 2019, 9:49 AM
P105 Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.H. Kim1, J.B. Ahn2, D.H. Kim1, S. Kim3, H.W. Ma1, X. Che1, D.H. Seo1, T.I. Kim1, W.H. Kim3, J.H. Cheon1, S.W. KimResearch Professor1

Created: Thursday, 30 January 2020, 10:12 AM
P105: An experimental examination of appetite and disordered eating in Crohn's disease patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Wardle R.1, Thapaliya G.1, Nowak A.1, Dalton M.2, Finlayson G.2, Moran G.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P105: Can patients enter the ‘Standard Set’ ICHOM parameters by completing electronic questionnaires?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Walsh*1, R. Kantchuster1, L. Matini1, J. Wilson1, M. Lepetyukh1, R. Palmer1, O. Brain1, S. Keshav1, S. Travis1

Created: Friday, 22 February 2019, 9:41 AM
P105: Coping in Inflammatory Bowel Disease: insights from the Crohn’s and Colitis UK national survey
Year: 2021
Source: ECCO'21 Virtual
Authors: MarshallMr, J.(1);Rowse, G.(2);Hollobone, S.(3);Afhim, S.(3);Oliver, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P105: Epithelial microRNA signatures as potential biomarkers in Crohn's disease related to clinical and endoscopic activity
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Moon, J.M.(1)*;Kim, K.U.(2);Shin, S.Y.(1);Joo, H.J.(1);Min, H.(2);Choi, C.H.(1);
Created: Friday, 14 July 2023, 10:48 AM
P105: Human neutrophil elastase degrades the therapeutic monoclonal antibodies effective in IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Kok1,2*, R. Curciarello3, T. Sobande1, S. Jones1, G. Docena3, T. MacDonald1

Created: Thursday, 21 February 2019, 9:14 AM
P105: Inhibition of cytokine release from HT-29 cells and ulcerative colitis biopsies is potentiated by combination of selective kinase inhibitors, and such effects are mimicked by TOP1210, a narrow spectrum kinase inhibitor
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. R. Foster*1, P. Biancheri2, S. Sirohi1, Y. Solanke1, M. C. Fyfe1, A. Rowley1, T. T. MacDonald2, E. Wood3, S. Webber1, C. A. Walshe1

Created: Friday, 22 February 2019, 9:49 AM
P105: Treatment of the lower gastrointestinal tract Klebsiella infections by recombinant bacteriocin KvarIa
Year: 2022
Source: ECCO'22
Authors: Karaliute, I.(1);Ramonaite, R.(1);Kupcinskas, J.(2);Misiunas, A.(3);Denkovskiene, E.(3);Gleba, Y.(4);Razanskiene, A.(3);Skieceviciene, J.(1);
Created: Friday, 11 February 2022, 3:52 PM